These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 31037157)

  • 21. Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression.
    Friedman GK; Bernstock JD; Chen D; Nan L; Moore BP; Kelly VM; Youngblood SL; Langford CP; Han X; Ring EK; Beierle EA; Gillespie GY; Markert JM
    Sci Rep; 2018 Sep; 8(1):13930. PubMed ID: 30224769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment.
    Meisen WH; Wohleb ES; Jaime-Ramirez AC; Bolyard C; Yoo JY; Russell L; Hardcastle J; Dubin S; Muili K; Yu J; Caligiuri M; Godbout J; Kaur B
    Clin Cancer Res; 2015 Jul; 21(14):3274-85. PubMed ID: 25829396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncolytic Virotherapy Blockade by Microglia and Macrophages Requires STAT1/3.
    Delwar ZM; Kuo Y; Wen YH; Rennie PS; Jia W
    Cancer Res; 2018 Feb; 78(3):718-730. PubMed ID: 29118089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy.
    Duebgen M; Martinez-Quintanilla J; Tamura K; Hingtgen S; Redjal N; Wakimoto H; Shah K
    J Natl Cancer Inst; 2014 Jun; 106(6):dju090. PubMed ID: 24838834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model.
    Thu MS; Najbauer J; Kendall SE; Harutyunyan I; Sangalang N; Gutova M; Metz MZ; Garcia E; Frank RT; Kim SU; Moats RA; Aboody KS
    PLoS One; 2009 Sep; 4(9):e7218. PubMed ID: 19787043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting GBM with an Oncolytic Picornavirus SVV-001 alone and in combination with fractionated Radiation in a Novel Panel of Orthotopic PDX models.
    Zhang H; Du Y; Qi L; Xiao S; Braun FK; Kogiso M; Huang Y; Huang F; Abdallah A; Suarez M; Karthick S; Ahmed NM; Salsman VS; Baxter PA; Su JM; Brat DJ; Hellenbeck PL; Teo WY; Patel AJ; Li XN
    J Transl Med; 2023 Jul; 21(1):444. PubMed ID: 37415222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maintaining and loading neural stem cells for delivery of oncolytic adenovirus to brain tumors.
    Ahmed AU; Ulasov IV; Mercer RW; Lesniak MS
    Methods Mol Biol; 2012; 797():97-109. PubMed ID: 21948472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
    Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E
    Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive therapy of brain cancer using a unique systemic delivery methodology with a cancer terminator virus.
    Bhoopathi P; Mannangatti P; Pradhan AK; Kumar A; Maji S; Lang FF; Klibanov AL; Madan E; Cavenee WK; Keoprasert T; Sun D; Bjerkvig R; Thorsen F; Gogna R; Das SK; Emdad L; Fisher PB
    J Cell Physiol; 2024 Aug; 239(8):e31302. PubMed ID: 38775127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adipose-derived stem cells as therapeutic delivery vehicles of an oncolytic virus for glioblastoma.
    Josiah DT; Zhu D; Dreher F; Olson J; McFadden G; Caldas H
    Mol Ther; 2010 Feb; 18(2):377-85. PubMed ID: 19904233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.
    Kazimirsky G; Jiang W; Slavin S; Ziv-Av A; Brodie C
    Stem Cell Res Ther; 2016 Oct; 7(1):149. PubMed ID: 27724977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Recombinant Oncolytic Virus VV-GMCSF-Lact and Chemotherapy Drugs against Human Glioma.
    Vasileva N; Ageenko A; Byvakina A; Sen'kova A; Kochneva G; Mishinov S; Richter V; Kuligina E
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irradiation enhances the therapeutic effect of the oncolytic adenovirus XVir-N-31 in brain tumor initiating cells.
    Czolk R; Schwarz N; Koch H; Schötterl S; Wuttke TV; Holm PS; Huber SM; Naumann U
    Int J Mol Med; 2019 Oct; 44(4):1484-1494. PubMed ID: 31432139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial.
    Fares J; Ahmed AU; Ulasov IV; Sonabend AM; Miska J; Lee-Chang C; Balyasnikova IV; Chandler JP; Portnow J; Tate MC; Kumthekar P; Lukas RV; Grimm SA; Adams AK; Hébert CD; Strong TV; Amidei C; Arrieta VA; Zannikou M; Horbinski C; Zhang H; Burdett KB; Curiel DT; Sachdev S; Aboody KS; Stupp R; Lesniak MS
    Lancet Oncol; 2021 Aug; 22(8):1103-1114. PubMed ID: 34214495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials.
    Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma.
    Chastkofsky MI; Pituch KC; Katagi H; Zannikou M; Ilut L; Xiao T; Han Y; Sonabend AM; Curiel DT; Bonner ER; Nazarian J; Horbinski CM; James CD; Saratsis AM; Hashizume R; Lesniak MS; Balyasnikova IV
    Clin Cancer Res; 2021 Mar; 27(6):1766-1777. PubMed ID: 33272983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models.
    Saha D; Wakimoto H; Peters CW; Antoszczyk SJ; Rabkin SD; Martuza RL
    Clin Cancer Res; 2018 Jul; 24(14):3409-3422. PubMed ID: 29599413
    [No Abstract]   [Full Text] [Related]  

  • 38. Zika Virus: A Neurotropic Warrior against High-Grade Gliomas-Unveiling Its Potential for Oncolytic Virotherapy.
    Calderón-Peláez MA; Maradei Anaya SJ; Bedoya-Rodríguez IJ; González-Ipuz KG; Vera-Palacios D; Buitrago IV; Castellanos JE; Velandia-Romero ML
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bevacizumab with angiostatin-armed oHSV increases antiangiogenesis and decreases bevacizumab-induced invasion in U87 glioma.
    Zhang W; Fulci G; Buhrman JS; Stemmer-Rachamimov AO; Chen JW; Wojtkiewicz GR; Weissleder R; Rabkin SD; Martuza RL
    Mol Ther; 2012 Jan; 20(1):37-45. PubMed ID: 21915104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.